Photo: Getty Images
This is exciting news!!! In a small trial with just 12 patients, each was given dostarlimb for six months to treat rectal cancer.
And by the end of the trial EVERY patient's scans came back completely clear and there was no identifiable cancer.
During the trial, the patients took the drug every three weeks for six months and if the tumors returned the patients were to do the standard chemotherapy and surgery, but the tumors never returned.